Research and Development Tax Credit Extension Act of 2013

HR 905 Research an d Development Tax Credit Extension Act of 2013 S. 2511 SAFE Retirement Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 892, to amend the Internal Revenue Code of 1986 to provide for S corporation reform. H.R. 905, to amend the Internal Revenue Code of 1986 to make the research credit permanent and to increase the alternative simplified research credit. H.R. 1554, to restrict the use of offshore tax havens and abusive tax shelters to inappropriately avoid federal taxation, and for other purposes. H.R. 1555, to amend the Internal Revenue Code of 1986 to reduce international tax avoidance and restore a level playing field for American businesses. H.R. 1556, to prevent corporations from exploiting tax treaties to evade taxation of U.S. income. H.R. 2194, to improve access to health care through expanded health savings accounts. H.R. 2708, to amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty. H.R. 2709, to extend the Generalized System of Preferences; to Ways & Means. H.R. 3331, to ensure that persons who form corporations or limited liability companies in the U.S. disclose the beneficial owners of those corporations or limited liability companies to prevent wrongdoers from exploiting U.S. corporations and limited liability companies for criminal gain, to assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, and other misconduct involving U.S. corporations and limited liability companies, and for other purposes. H.R. 4464, to amend the Internal Revenue Code of 1986 to make permanent the look-through treatment of payments between related controlled foreign corporations. H.R.4503 -- Fair Playing Field Act of 2014, to permit the Secretary of the Treasury to issue prospective guidance clarifying the employment status of individuals for purposes of employment taxes and to prevent retroactive assessments with respect to such clarifications. S. 250, to amend the Internal Revenue Code of 1986 to modify the treatment of foreign corporations, and for other purposes. S. 268, to reduce the deficit and protect important programs by ending tax loopholes. S. 743, to restore states' sovereign rights to enforce state and local sales and use tax laws, and for other purposes. S. 1031, to amend the IRC of 1986 to improve access to health care through expanded health savings accounts. S. 1431, to permanently extend the Internet Tax Freedom Act. S. 1465, to ensure that persons who form corporations in the United States disclose the beneficial owners of those corporations, in order to prevent the formation of corporations with hidden owners, stop the misuse of U.S. corporations by wrongdoers, and assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, tax evasion, and other criminal and civil misconduct involving U.S. corporations, and for other purposes. S. 1489, to amend the Internal Revenue Code of 1986 to require the secretary of the treasury to notify the taxpayer each time the taxpayer's information is accessed by the Internal Revenue Service. S. 2600, the Marketplace and Internet Tax Fairness Act. S. 2609, the Marketplace and Internet Tax Fairness Act.

S.232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax medical devices H.R. 905 - Research and Development Tax Credit Extension Act of 2013 - Amends the Internal Revenue Code to (1) make permanent the tax credit for increasing research activities, (2)increase the rate of the alternative simplified research tax credit H.R. 1295 - Medical Device Tax Elimination Act - Extends and enhances R&P tax credit H.R. 905 - Research and Development Tax Credit Extension Act of 2013 Comprehensive/Corporate tax reform Chairman's W&M Discussion Draft - Including lower corporate tax rate, research credit transition and base erosion Tax Reform Act of 2014 - A comprehensive bill to reform the nation's tax system Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act - A bill to extend a number of lapsed tax provisions

Client expense: $420,000 · Firm income: Not reported

HR 905 Research and Development Tax Credit Extension Act of 2013

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

ASP reimbursement policy Pharmaceutical distribution management HR905/S733- excluding customary prompt pay discounts from Medicare

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 892, to amend the Internal Revenue Code of 1986 to provide for S corporation reform, and for other purposes. H.R. 905, to amend the Internal Revenue Code of 1986 to make the research credit permanent and to increase the alternative simplified research credit.H.R. 1554, to restrict the use of offshore tax havens and abusive tax shelters to inappropriately avoid federal taxation, and for other purposes. H.R. 1555, to amend the Internal Revenue Code of 1986 to reduce international tax avoidance and restore a level playing field for American businesses. H.R. 1556, to prevent corporations from exploiting tax treaties to evade taxation of U.S. income. H.R. 2194, to improve access to health care through expanded health savings accounts. H.R. 2708, to amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty. H.R. 2709, to extend the Generalized System of Preferences; to Ways & Means. H.R. 3331, to ensure that persons who form corporations or limited liability companies in the U.S. disclose the beneficial owners of those corporations or limited liability companies to prevent wrongdoers from exploiting U.S. corporations and limited liability companies for criminal gain, to assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, and other misconduct involving U.S. corporations and limited liability companies, and for other purposes. H.R. 4464, to amend the Internal Revenue Code of 1986 to make permanent the look-through treatment of payments between related controlled foreign corporations. H.R.4503 -- Fair Playing Field Act of 2014, to permit the Secretary of the Treasury to issue prospective guidance clarifying the employment status of individuals for purposes of employment taxes and to prevent retroactive assessments with respect to such clarifications. S. 250, to amend the Internal Revenue Code of 1986 to modify the treatment of foreign corporations, and for other purposes. S. 268, to reduce the deficit and protect important programs by ending tax loopholes. S. 743, to restore states' sovereign rights to enforce state and local sales and use tax laws, and for other purposes. S. 1031, to amend the IRC of 1986 to improve access to health care through expanded health savings accounts. S. 1431, to permanently extend the Internet Tax Freedom Act. S. 1465, to ensure that persons who form corporations in the United States disclose the beneficial owners of those corporations, in order to prevent the formation of corporations with hidden owners, stop the misuse of U.S. corporations by wrongdoers, and assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, tax evasion, and other criminal and civil misconduct involving U.S. corporations, and for other purposes. S. 1489, to amend the Internal Revenue Code of 1986 to require the secretary of the treasury to notify the taxpayer each time the taxpayer's information is accessed by the Internal Revenue Service. S. 2600, the Marketplace and Internet Tax Fairness Act.

ASP reimbursement policy Pharmaceutical distribution management HR905/S733-- excluding customary prompt pay discounts from Medicare

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax medical devices H.R. 905 - Research and Development Tax Credit Extension Act of 2013 - Amends the Internal Revenue Code to: (1) make permanent the tax credit for increasing research activities, (2) increase the rate of the alternative simplified research tax credit H.R. 1295 - Medical Device Tax Elimination Act - Extends and enhances R&P tax credit H.R. 905 - Research and Develpment Tax Credit Extension Act of 2013 Comprehensive/Corporate tax reform Chairman's W&M Discussion Draft - Including lower corporate tax rate, research credit transition and base erosion Tax Reform Act of 2014 - A comprehensive bill to reform the nation's tax system. Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act - A bill to extend a number of lapsed tax provision.

Client expense: $450,000 · Firm income: Not reported

HR 905 Research and Development Tax Credit Extension Act of 2013

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 31/HR 434 - Internet Tax Freedom Act (provisions related to taxation on Internet access and electronic commerce); S 151 - Restoring America's Competitiveness in Enterprise (RACE) Act of 2013 (provisions related to the corporate tax rate); S 213 - Telephone Excise Tax Elimination Act of 2013 (provisions related to amending the Internal Revenue Service code of 1986 to repeal the excise tax on telephone and other communications services); S 268 - CUT Loopholes Act (provisions related to tax treatment of controlled foreign corporations); S 250 - Corporate Tax Dodging Prevention Act (provisions related to tax treatment of controlled foreign corporations); S 743/HR 684 - Marketplace Fairness Act of 2013 (provisions related to sourcing issues for interstate sales and telecom tax simplification); S 1235/HR 2309 - Wireless Tax Fairness Act (provisions related to restrictions on any state or local jurisdiction from imposing a new discriminatory tax on cell phone services, providers or property); S. 1364 - Digital Goods and Services Tax Fairness Act (provisions that promote neutrality, simplicity and fairness in the taxation of digital goods and services); S. 1431 - Internet Tax Freedom Act (provisions related to taxation of Internet Service Providers; S. 1645/HR 1295 - Medical Device Tax Elimination Act (provisions related to the excise tax on medical devices); S Amendment 578 to S Con Res 8 - To establish a deficit-neutral reserve fund to ensure marketplace fairness by allowing States to enforce State and local use tax laws (provisions related to sales tax); S Amendment 581 to S Con Res 8 - To exempt remote sales of business inputs (provisions related to sales tax); H.R. 434/S. 31 - Internet Tax Freedom Act (provisions related to taxation on Internet Access and electronic commerce); HR 694 - Corporate Tax Fairness Act (provisions related to tax treatment of controlled foreign corporations); HR 905 - Research and Development Tax Credit Extension Act of 2013 (provisions related to extending the research credit); H Con Res 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 (provisions related to the corporate tax rate); HR 1129 - Mobile Workforce State Income Tax Simplification Act of 2013 (provisions related to changes to non-resident personal income tax returns); and H.R. 3086 - Permanent Internet Tax Freedom Act (provisions related to taxation on Internet Service Providers.

H.R. 892, to amend the Internal Revenue Code of 1986 to provide for S corporation reform, and for other purposes. H.R. 905, to amend the Internal Revenue Code of 1986 to make the research credit permanent and to increase the alternative simplified research credit.H.R. 1554, to restrict the use of offshore tax havens and abusive tax shelters to inappropriately avoid federal taxation, and for other purposes. H.R. 1555, to amend the Internal Revenue Code of 1986 to reduce international tax avoidance and restore a level playing field for American businesses. H.R. 1556, to prevent corporations from exploiting tax treaties to evade taxation of U.S. income. H.R. 2194, to improve access to health care through expanded health savings accounts. H.R. 2708, to amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty. H.R. 2709, to extend the Generalized System of Preferences; to Ways & Means. H.R. 3331, to ensure that persons who form corporations or limited liability companies in the U.S. disclose the beneficial owners of those corporations or limited liability companies to prevent wrongdoers from exploiting U.S. corporations and limited liability companies for criminal gain, to assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, and other misconduct involving U.S. corporations and limited liability companies, and for other purposes. H.R. 4464, to amend the Internal Revenue Code of 1986 to make permanent the look-through treatment of payments between related controlled foreign corporations. S. 250, to amend the Internal Revenue Code of 1986 to modify the treatment of foreign corporations, and for other purposes. S. 268, to reduce the deficit and protect important programs by ending tax loopholes. S. 743, to restore states' sovereign rights to enforce state and local sales and use tax laws, and for other purposes. S. 1031, to amend the IRC of 1986 to improve access to health care through expanded health savings accounts. S. 1431, to permanently extend the Internet Tax Freedom Act. S. 1465, to ensure that persons who form corporations in the United States disclose the beneficial owners of those corporations, in order to prevent the formation of corporations with hidden owners, stop the misuse of U.S. corporations by wrongdoers, and assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, tax evasion, and other criminal and civil misconduct involving U.S. corporations, and for other purposes. S. 1489, to amend the Internal Revenue Code of 1986 to require the secretary of the treasury to notify the taxpayer each time the taxpayer's information is accessed by the Internal Revenue Service.

HR 905 Research and Development Tax Credit Extension Act of 2013

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

ASP reimbursement policy Pharmaceutical distribution reimbursement HR905/S733- excluding customary prompt pay discounts from Medicare

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Tax reform issues related to corporate tax rates, taxes on corporate dividends and certain tax extender provisions.HR 905, Research and Development Tax Credit Extension Act of 2013, as it relates to extending the research credit H Con Res 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023, provisions related to the corporate tax rate S 743/HR 684, Marketplace Fairness Act of 2013, as it relates to sourcing issues for interstate sales and telecom tax simplification S 213, Telephone Excise Tax Elimination Act of 2013, as it relates to amending the Internal Revenue Service code of 1986 to repeal the excise tax on telephone and other communications services S 268, CUT Loopholes Act, as it relates to tax treatment of controlled foreign corporations S 250, Corporate Tax Dodging Prevention Act, as it relates to tax treatment of controlled foreign corporations HR 694, Corporate Tax Fairness Act, as it relates to tax treatment of controlled foreign corporations HR 1295, Medical Device Tax Elimination Act, as it relates to the excise tax on medical devices S 151, Restoring America's Competitiveness in Enterprise (RACE) Act of 2013, provisions related to the corporate tax rate S Amendment 578 to S Con Res 8, To establish a deficit-neutral reserve fund to ensure marketplace fairness by allowing States to enforce State and local use tax laws, as it relates to sales tax S Amendment 581 to S Con Res 8, To exempt remote sales of business inputs, as it relates to sales tax HR 434/S 31, Internet Tax Freedom Act, provisions related to taxation on Internet access and electronic commerce HR 1129/S 1645, Mobile Workforce State Income Tax Simplification Act of 2013, as it relates to changes to non-resident personal income tax returns S 1235/HR 2309, Wireless Tax Fairness Act, as it relates to restrictions on any state or local jurisdiction from imposing a new discriminatory tax on cell phone services, providers or property S 1364, Digital Goods and Services Tax Fairness Act, provisions that promote neutrality, simplicity and fairness in the taxation of digital goods and services HR 3086, Permanent Internet Tax Freedom Act, provisions related to taxation on internet service providers S 1431, Internet Tax Freedom Act, provisions related to taxation on internet service providers Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act, as it relates to bonus depreciation The Tax Reform Act of 2014, provisions related to the corporate tax rate

S.232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax medical devices H.R. 905 - Research and Development Tax Credit Extension Act of 2013 - Amends the Internal Revenue Code to: (1) make permanent the tax credit for increasing research activities, (2) increase the rate of the alternative simplified research tax credit H.R. 1295 - Medical Device Tax Elimination Act - Extends and enhances R&P tax credit H.R. 905 - Research and Development Tax Credit Extension Act of 2013 Comprehensive/Corporate tax reform Chairman's W&M Discussion Draft - Including lower corporate tax rate, research credit transition and base erosion Tax Reform Act of 2014 - A comprehensive bill to reform the nations' tax system. Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act. - A bill to extend a number of lapsed tax provisions.

Client expense: $450,489 · Firm income: Not reported

S 31/HR 434 - Internet Tax Freedom Act (provisions related to taxation on Internet access and electronic commerce); S 151 - Restoring America's Competitiveness in Enterprise (RACE) Act of 2013 (provisions related to the corporate tax rate); S 213 - Telephone Excise Tax Elimination Act of 2013 (provisions related to amending the Internal Revenue Service code of 1986 to repeal the excise tax on telephone and other communications services); S 268 - CUT Loopholes Act (provisions related to tax treatment of controlled foreign corporations); S 250 - Corporate Tax Dodging Prevention Act (provisions related to tax treatment of controlled foreign corporations); S 743/HR 684 - Marketplace Fairness Act of 2013 (provisions related to sourcing issues for interstate sales and telecom tax simplification); S 1235/HR 2309 - Wireless Tax Fairness Act (provisions related to restrictions on any state or local jurisdiction from imposing a new discriminatory tax on cell phone services, providers or property); S. 1364 - Digital Goods and Services Tax Fairness Act (provisions that promote neutrality, simplicity and fairness in the taxation of digital goods and services); S. 1431 - Internet Tax Freedom Act (provisions related to taxation of Internet Service Providers; S Amendment 578 to S Con Res 8 - To establish a deficit-neutral reserve fund to ensure marketplace fairness by allowing States to enforce State and local use tax laws (provisions related to sales tax); S Amendment 581 to S Con Res 8 - To exempt remote sales of business inputs (provisions related to sales tax); H.R. 434/S. 31 - Internet Tax Freedom Act (provisions related to taxation on Internet Access and electronic commerce); HR 694 - Corporate Tax Fairness Act (provisions related to tax treatment of controlled foreign corporations); HR 905 - Research and Development Tax Credit Extension Act of 2013 (provisions related to extending the research credit); H Con Res 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 (provisions related to the corporate tax rate); HR 1129 - Mobile Workforce State Income Tax Simplification Act of 2013 (provisions related to changes to non-resident personal income tax returns); HR 1295 - Medical Device Tax Elimination Act (provisions related to the excise tax on medical devices); and H.R. 3086 - Permanent Internet Tax Freedom Act (provisions related to taxation on Internet Service Providers).

S 31/HR 434 - Internet Tax Freedom Act (provisions related to taxation on Internet access and electronic commerce); S 151 - Restoring America's Competitiveness in Enterprise (RACE) Act of 2013 (provisions related to the corporate tax rate); S 213 - Telephone Excise Tax Elimination Act of 2013 (provisions related to amending the Internal Revenue Service code of 1986 to repeal the excise tax on telephone and other communications services); S 268 - CUT Loopholes Act (provisions related to tax treatment of controlled foreign corporations); S 250 - Corporate Tax Dodging Prevention Act (provisions related to tax treatment of controlled foreign corporations); S 743/HR 684 - Marketplace Fairness Act of 2013 (provisions related to sourcing issues for interstate sales and telecom tax simplification); S 1235/HR 2309 - Wireless Tax Fairness Act (provisions related to restrictions on any state or local jurisdiction from imposing a new discriminatory tax on cell phone services, providers or property); S. 1364 - Digital Goods and Services Tax Fairness Act (provisions that promote neutrality, simplicity and fairness in the taxation of digital goods and services); S. 1431 - Internet Tax Freedom Act (provisions related to taxation of Internet Service Providers; S Amendment 578 to S Con Res 8 - To establish a deficit-neutral reserve fund to ensure marketplace fairness by allowing States to enforce State and local use tax laws (provisions related to sales tax); S Amendment 581 to S Con Res 8 - To exempt remote sales of business inputs (provisions related to sales tax); H.R. 434/S. 31 - Internet Tax Freedom Act (provisions related to taxation on Internet Access and electronic commerce); HR 694 - Corporate Tax Fairness Act (provisions related to tax treatment of controlled foreign corporations); HR 905 - Research and Development Tax Credit Extension Act of 2013 (provisions related to extending the research credit); H Con Res 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 (provisions related to the corporate tax rate); HR 1129 - Mobile Workforce State Income Tax Simplification Act of 2013 (provisions related to changes to non-resident personal income tax returns); HR 1295 - Medical Device Tax Elimination Act (provisions related to the excise tax on medical devices); and H.R. 3086 - Permanent Internet Tax Freedom Act (provisions related to taxation on Internet Service Providers.

H.R. 892, to amend the Internal Revenue Code of 1986 to provide for S corporation reform, and for other purposes. H.R. 905, to amend the Internal Revenue Code of 1986 to make the research credit permanent and to increase the alternative simplified research credit.H.R. 1554, to restrict the use of offshore tax havens and abusive tax shelters to inappropriately avoid federal taxation, and for other purposes. H.R. 1555, to amend the Internal Revenue Code of 1986 to reduce international tax avoidance and restore a level playing field for American businesses. H.R. 1556, to prevent corporations from exploiting tax treaties to evade taxation of U.S. income. H.R. 2194, to improve access to health care through expanded health savings accounts. H.R. 2708, to amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty. H.R. 2709, to extend the Generalized System of Preferences; to Ways & Means. H.R. 3331, to ensure that persons who form corporations or limited liability companies in the U.S. disclose the beneficial owners of those corporations or limited liability companies to prevent wrongdoers from exploiting U.S. corporations and limited liability companies for criminal gain, to assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, and other misconduct involving U.S. corporations and limited liability companies, and for other purposes. S. 250, to amend the Internal Revenue Code of 1986 to modify the treatment of foreign corporations, and for other purposes. S. 268, to reduce the deficit and protect important programs by ending tax loopholes. S. 743, to restore states' sovereign rights to enforce state and local sales and use tax laws, and for other purposes. S. 1031, to amend the IRC of 1986 to improve access to health care through expanded health savings accounts. S. 1431, to permanently extend the Internet Tax Freedom Act. S. 1465, to ensure that persons who form corporations in the United States disclose the beneficial owners of those corporations, in order to prevent the formation of corporations with hidden owners, stop the misuse of U.S. corporations by wrongdoers, and assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, tax evasion, and other criminal and civil misconduct involving U.S. corporations, and for other purposes. S. 1489, to amend the Internal Revenue Code of 1986 to require the secretary of the treasury to notify the taxpayer each time the taxpayer's information is accessed by the Internal Revenue Service; to Finance.

HR 905 - Research and Development Tax Credit Extension Act of 2013

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Tax reform issues related to corporate tax rates, taxes on corporate dividends and certain tax extender provisions.HR 905, Research and Development Tax Credit Extension Act of 2013, as it relates to extending the research credit H Con Res 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023, provisions related to the corporate tax rate S 743/HR 684, Marketplace Fairness Act of 2013, as it relates to sourcing issues for interstate sales and telecom tax simplification S 213, Telephone Excise Tax Elimination Act of 2013, as it relates to amending the Internal Revenue Service code of 1986 to repeal the excise tax on telephone and other communications services S 268, CUT Loopholes Act, as it relates to tax treatment of controlled foreign corporations S 250, Corporate Tax Dodging Prevention Act, as it relates to tax treatment of controlled foreign corporations HR 694, Corporate Tax Fairness Act, as it relates to tax treatment of controlled foreign corporations HR 1295, Medical Device Tax Elimination Act, as it relates to the excise tax on medical devices S 151, Restoring America's Competitiveness in Enterprise (RACE) Act of 2013, provisions related to the corporate tax rate S Amendment 578 to S Con Res 8, To establish a deficit-neutral reserve fund to ensure marketplace fairness by allowing States to enforce State and local use tax laws, as it relates to sales tax S Amendment 581 to S Con Res 8, To exempt remote sales of business inputs, as it relates to sales tax HR 434/S 31, Internet Tax Freedom Act, provisions related to taxation on Internet access and electronic commerce HR 1129/S 1645, Mobile Workforce State Income Tax Simplification Act of 2013, as it relates to changes to non-resident personal income tax returns S 1235/HR 2309, Wireless Tax Fairness Act, as it relates to restrictions on any state or local jurisdiction from imposing a new discriminatory tax on cell phone services, providers or property S 1364, Digital Goods and Services Tax Fairness Act, provisions that promote neutrality, simplicity and fairness in the taxation of digital goods and services HR 3086, Permanent Internet Tax Freedom Act, provisions related to taxation on internet service providers S 1431, Internet Tax Freedom Act, provisions related to taxation on internet service providers

GENERAL DISCUSSIONS REGARDING TAX REFORM; ISSUES RELATED TO PASS-THROUGHS AND CASH METHODS OF ACCOUNTINGHR 119: TO AMEND THE INTERNAL REVENUE CODE TO MAKE PERMANENT THE CREDIT FOR INCREASING RESEARCH ACTIVITIES; PROVISIONS RELATED TO RESEARCH AND DEVELOPMENT TAX CREDIT HR 905: RESEARCH AND DEVELOPMENT TAX CREDIT EXTENSION ACT OF 2013; PROVISIONS RELATED TO RESEARCH AND DEVELOPMENT TAX CREDIT HR 1129: MOBILE WORKFORCE STATE INCOME TAX SIMPLIFICATION ACT OF 2013; PROVISIONS RELATED TO STATE TAX MOBILITY S 193: STARTUP INNOVATION CREDIT ACT OF 2013; PROVISIONS RELATED TO RESEARCH AND DEVELOPMENT TAX CREDIT

Client expense: $190,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

ASP reimbursement policy Pharmaceutical distribution reimbursement HR905/S733- excluding customary prompt pay discounts from Medicare

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax medical devices H.R. 905 - Research and Development Tax Credit Extension Act of 2013 - Amends the Internal Revenue Code to: (1) make permanent the tax credit for increasing research activities, (2) increase the rate of the alternative simplified research tax credit H.R. 1295 - Medical Device Tax Elimination Act - Extends and enhances R&P tax credit H.R. 905 - Research and Development Tax Credit Extension Act of 2013 Comprehensive/Corporate tax reform Chairman's W&M Discussion Draft - Including lower corportae tax rate, research credit transition and base erosion

Client expense: $400,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

S.232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax medical devicesH.R. 905 - Research and Development Tax Credit Extension Act of 2013 - Amends the Internal Revenue Code to: (1) make permanent the tax credit for increasing research activities, (2) increase the rate of the alternative simplified research tax credit H.R. 1295 - Medical Device Tax Elimination Act - Extends and enhances R&P tax credit H.R. 905 - Research and Development Tax Credit Extension Act of 2013 Comprehensive/Corporate tax reform Chairman's W&M Discussion Draft - Including lower corportae tax rate, research credit transition and base erosion

Client expense: $400,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

HR 905 - Research and Development Tax Credit Extension Act of 2013

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 892, to amend the Internal Revenue Code of 1986 to provide for S corporation reform, and for other purposes. H.R. 905, to amend the Internal Revenue Code of 1986 to make the research credit permanent and to increase the alternative simplified research credit.H.R. 1554, to restrict the use of offshore tax havens and abusive tax shelters to inappropriately avoid federal taxation, and for other purposes. H.R. 1555, to amend the Internal Revenue Code of 1986 to reduce international tax avoidance and restore a level playing field for American businesses. H.R. 1556, to prevent corporations from exploiting tax treaties to evade taxation of U.S. income. H.R. 2194, to improve access to health care through expanded health savings accounts. H.R. 2708, to amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty. H.R. 2709, to extend the Generalized System of Preferences; to Ways & Means. S. 250, to amend the Internal Revenue Code of 1986 to modify the treatment of foreign corporations, and for other purposes. S. 268, to reduce the deficit and protect important programs by ending tax loopholes. S. 743, to restore states' sovereign rights to enforce state and local sales and use tax laws, and for other purposes. S. 1031, to amend the IRC of 1986 to improve access to health care through expanded health savings accounts. S. 1431, to permanently extend the Internet Tax Freedom Act. S. 1465, to ensure that persons who form corporations in the United States disclose the beneficial owners of those corporations, in order to prevent the formation of corporations with hidden owners, stop the misuse of U.S. corporations by wrongdoers, and assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, tax evasion, and other criminal and civil misconduct involving U.S. corporations, and for other purposes. S. 1489, to amend the Internal Revenue Code of 1986 to require the secretary of the treasury to notify the taxpayer each time the taxpayer's information is accessed by the Internal Revenue Service; to Finance.

H.R. 892, to amend the Internal Revenue Code of 1986 to provide for S corporation reform, and for other purposes. H.R. 905, to amend the Internal Revenue Code of 1986 to make the research credit permanent and to increase the alternative simplified research credit.H.R. 1554, to restrict the use of offshore tax havens and abusive tax shelters to inappropriately avoid federal taxation, and for other purposes. H.R. 1555, to amend the Internal Revenue Code of 1986 to reduce international tax avoidance and restore a level playing field for American businesses. H.R. 1556, to prevent corporations from exploiting tax treaties to evade taxation of U.S. income. H.R. 2194, to improve access to health care through expanded health savings accounts. H.R. 2708, to amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty. H.R. 2709, to extend the Generalized System of Preferences; to Ways & Means. S. 250, to amend the Internal Revenue Code of 1986 to modify the treatment of foreign corporations, and for other purposes. S. 268, to reduce the deficit and protect important programs by ending tax loopholes. S. 743, to restore states' sovereign rights to enforce state and local sales and use tax laws, and for other purposes. S. 1031, to amend the IRC of 1986 to improve access to health care through expanded health savings accounts. S. 1431, to permanently extend the Internet Tax Freedom Act. S. 1465, to ensure that persons who form corporations in the United States disclose the beneficial owners of those corporations, in order to prevent the formation of corporations with hidden owners, stop the misuse of U.S. corporations by wrongdoers, and assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, tax evasion, and other criminal and civil misconduct involving U.S. corporations, and for other purposes. S. 1489, to amend the Internal Revenue Code of 1986 to require the secretary of the treasury to notify the taxpayer each time the taxpayer's information is accessed by the Internal Revenue Service; to Finance.

GENERAL DISCUSSIONS REGARDING TAX REFORM; ISSUES RELATED TO PASS-THROUGHS AND CASH METHODS OF ACCOUNTINGHR 119: TO AMEND THE INTERNAL REVENUE CODE TO MAKE PERMANENT THE CREDIT FOR INCREASING RESEARCH ACTIVITIES; PROVISIONS RELATED TO RESEARCH AND DEVELOPMENT TAX CREDIT HR 905: RESEARCH AND DEVELOPMENT TAX CREDIT EXTENSION ACT OF 2013; PROVISIONS RELATED TO RESEARCH AND DEVELOPMENT TAX CREDIT HR 1129: MOBILE WORKFORCE STATE INCOME TAX SIMPLIFICATION ACT OF 2013; PROVISIONS RELATED TO STATE TAX MOBILITY S 193: STARTUP INNOVATION CREDIT ACT OF 2013; PROVISIONS RELATED TO RESEARCH AND DEVELOPMENT TAX CREDIT

Client expense: $180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax medical devicesH.R. 905 - Research and Development Tax Credit Extension Act of 2013 - Amends the Internal Revenue Code to: (1) make permanent the tax credit for increasing research activities, (2) increase the rate of the alternative simplified research tax credit H.R. 1295 - Medical Device Tax Elimination Act - Extends and enhances R&P tax credit H.R. 905 - Research and Development Tax Credit Extension Act of 2013 Comprehensive/Corporate tax reform Chairman's W&M Discussion Draft - Including lower corporate tax rate, research credit transition and base erosion.

Client expense: $380,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

ASP reimbursement policy Pharmaceutical distribution reimbursement HR905/S733-- excluding customary prompt pay discount from Medicare

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 151, Restoring America's Competitiveness in Enterprise (RACE) Act of 2013 (provisions related to the corporate tax rate); S 213, Telephone Excise Tax Elimination Act of 2013 (provisions related to amending the Internal Revenue Service code of 1986 to repeal the excise tax on telephone and other communications services); S 268, CUT Loopholes Act (provisions related to tax treatment of controlled foreign corporations); S 250, Corporate Tax Dodging Prevention Act (provisions related to tax treatment of controlled foreign corporations); S 743/HR 684, Marketplace Fairness Act of 2013 (provisions related to sourcing issues for interstate sales and telecom tax simplification); S 1235/HR 2309, Wireless Tax Fairness Act (provisions related to restrictions on any state or local jurisdiction from imposing a new discriminatory tax on cell phone services, providers or property); S Amendment 578 to S Con Res 8, To establish a deficit-neutral reserve fund to ensure marketplace fairness by allowing States to enforce State and local use tax laws (provisions related to sales tax); S Amendment 581 to S Con Res 8, To exempt remote sales of business inputs (provisions related to sales tax); HR 694, Corporate Tax Fairness Act (provisions related to tax treatment of controlled foreign corporations); HR 905, Research and Development Tax Credit Extension Act of 2013 (provisions related to extending the research credit); H Con Res 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 (provisions related to the corporate tax rate); HR 1129, Mobile Workforce State Income Tax Simplification Act of 2013 (provisions related to changes to non-resident personal income tax returns); HR 1295, Medical Device Tax Elimination Act (provisions related to the excise tax on medical devices); Draft, Digital Goods and Services Tax Fairness Act (provisions that promote neutrality, simplicity and fairness in the taxation of digital goods and services); and General discussion of tax reform issues related to corporate tax rates and taxes on corporate dividends

H.R. 892, to amend the Internal Revenue Code of 1986 to provide for S corporation reform, and for other purposes. H.R. 905, to amend the Internal Revenue Code of 1986 to make the research credit permanent and to increase the alternative simplified research credit.H.R. 1554, to restrict the use of offshore tax havens and abusive tax shelters to inappropriately avoid federal taxation, and for other purposes. H.R. 1555, to amend the Internal Revenue Code of 1986 to reduce international tax avoidance and restore a level playing field for American businesses. H.R. 1556, to amend the Internal Revenue Code of 1986 to prevent corporations from exploiting tax treaties to evade taxation of U.S. income. H.R. 2194, to amend the Internal Revenue Code of 1986 to improve access to health care through expanded health savings accounts. H.R. 2708, to amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty. H.R. 2709, to extend the Generalized System of Preferences. S. 250, to amend the Internal Revenue Code of 1986 to modify the treatment of foreign corporations, and for other purposes. S. 268, to reduce the deficit and protect important programs by ending tax loopholes. S. 743, to restore states' sovereign rights to enforce state and local sales and use tax laws. S. 1031, to amend the Internal Revenue Code to improve access to health care through expanded health savings accounts.

Client expense: $110,000 · Firm income: Not reported

GENERAL DISCUSSIONS REGARDING TAX REFORMHR 119: TO AMEND THE INTERNAL REVENUE CODE TO MAKE PERMANENT THE CREDIT FOR INCREASING RESEARCH ACTIVITIES; PROVISIONS RELATED TO RESEARCH AND DEVELOPMENT TAX CREDIT HR 905: RESEARCH AND DEVELOPMENT TAX CREDIT EXTENSION ACT OF 2013; PROVISIONS RELATED TO RESEARCH AND DEVELOPMENT TAX CREDIT HR 1129: MOBILE WORKFORCE STATE INCOME TAX SIMPLIFICATION ACT OF 2013; PROVISIONS RELATED TO STATE TAX MOBILITY S 193: STARTUP INNOVATION CREDIT ACT OF 2013; PROVISIONS RELATED TO RESEARCH AND DEVELOPMENT TAX CREDIT

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Pandemic preparedness, Tamiflu, Medicare coverage of Cancer Drugs, Appropriations.; S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 1416, Cancer Patient Protection Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; compounding issues; FY 13 Labor HHS Appropriations legislation; issues related to FDA user fee reauthorization; H.R. 942 S. 1577; S. 3187; Pedigree and biologics issues; H.R. 905: ASP issues; H.R. 5651; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; implementation of section 340B of the Public Health Service Act (42 U.S.C. 256b); Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA stimulus. Avastin-use in breast cancer treatment: general patient reform isse: implementation of the Affordable Care Act of 2010; Issues relating to the treatment of biologics in international health programs.

Client expense: $1,077,000 · Firm income: Not reported

ASP reimbursement policy Pharmaceutical distribution reimbursement Drug Pedigree H.R.905/S.733-- excluding customary prompt pay discount from Medicare

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax medical devicesH.R. 905 - Research and Development Tax Credit Extension Act of 2013-Amends the Internal Revenue Code to: (1) make permanent the tax credit for increasing research activities, (2) increase the rate of the alternative simplified research tax credit. H.R. 1295 - Medical Device Tax Elimination Act - Extends and enhances R&P tax credit H.R. 905 - Research and Development Tax Credit Extension Act of 2013 Comprehensive/Corporate tax reform Chairman's W&M Discussion Draft - Including lower corporate tax rate, research credit, transition and base erosion

Client expense: $350,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

HR 905 - Research and Development Tax Credit Extension Act of 2013

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 892, to amend the Internal Revenue Code of 1986 to provide for S corporation reform, and for other purposes. H.R. 905, to amend the Internal Revenue Code of 1986 to make the research credit permanent and to increase the alternative simplified research credit.H.R. 1554, to restrict the use of offshore tax havens and abusive tax shelters to inappropriately avoid federal taxation, and for other purposes. H.R. 1555, to amend the Internal Revenue Code of 1986 to reduce international tax avoidance and restore a level playing field for American businesses. H.R. 1556, to amend the Internal Revenue Code of 1986 to prevent corporations from exploiting tax treaties to evade taxation of U.S. income. S. 250, to amend the Internal Revenue Code of 1986 to modify the treatment of foreign corporations, and for other purposes. S. 268, to reduce the deficit and protect important programs by ending tax loopholes. S. 743, to restore states' sovereign rights to enforce state and local sales and use tax laws, and for other purposes.

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)

Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 800, a bill to remove the prompt pay discount between the manufacturer and the distributor from the providers Medicare Part B drug reimbursement.H.R. 905/S.733, to amend Part B of title XVIII of the Social Security Act.

Client expense: $520,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ASP reimbursement policy Pharmaceutical distribution reimbursement H.R.905/S.733-- excluding customary prompt pay discount from ASP; Drug shortages

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax medical devicesH.R. 905 - Research and Development Tax Credit Extension Act of 2013-Amends the Internal Revenue Code to: (1) make permanent the tax credit for increasing research activities, (2) increase the rate of the alternative simplified research tax credit. H.R. 1295 - Medical Device Tax Elimination Act - Extends and enhances R&P tax credit H.R. 905 - Research and Development Tax Credit Extension Act of 2013 Comprehensive/Corporate tax reform Chairman's W&M Discussion Draft - Including lower corporate tax rate, research credit, transition and base erosion

Client expense: $350,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

HR 905 - Research and Development Tax Credit Extension Act of 2013

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES